DK

Disha Karale

Investor at BoxGroup

New York City Metropolitan Area

Overview 

Disha Karale is currently an Investor at BoxGroup, with previous experience at Accel, Allogene Therapeutics, and Celularity, Inc. She holds a Bachelor of Science in Economics from The Wharton School and a Bachelor of Arts from the University of Pennsylvania. Karale specializes in investing in various sectors including Drug Delivery, Digital Health, E-commerce, and AI, focusing on Seed and Pre-seed stages.

Work Experience 

B

BoxGroup

  • Investor

    2023 - Current

    Early Stage Investing

BoxGroup is an early-stage investment fund that invests in technology companies.

boxgroup.com
A

Accel

  • Investor

    2022 - 2022

    Growth Investing

Accel is an seed and growth-stage venture capital firm that helps a global community of entrepreneurs.

accel.com
AT

Allogene Therapeutics

  • R&D Scientist

    2021 - 2021

    Solid Tumor CAR-T Cell Immunotherapy Group

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Raised $891,770,409.00 from Franklin Templeton, Jennison Associates, venBio Select Advisor, Fidelity, Deerfield Capital Management, Surveyor Capital, Perceptive Advisors, T. Rowe Price and Cowen Investment Management.

allogene.com
CI

Celularity, Inc.

  • Researcher

    2018 - 2018

    Rotation Program in R&D, Process Development & Quality Control

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

Raised $400,000,011.00 from Sorrento Therapeutics, Dragasac Limited and Starr Insurance.

celularity.com

Education 

Articles About Disha

Relevant Websites